Clinical Trial Update: Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Exploratory Efficacy of Nimacimab in Patients With Diabetic Gastroparesis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating nimacimab for safety, tolerability, pharmacokinetics, and exploratory efficacy in diabetic gastroparesis; status currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Gastroparesis

Drugs mentioned

• Nimacimab (Nimacimab)

Snippet

Sponsor: Bird Rock Bio, Inc. | Conditions: Diabetic Gastroparesis | Phase 2 | Status: UNKNOWN